Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (36970) 36970
Newspaper Article (3837) 3837
Publication (2638) 2638
Newsletter (1305) 1305
Magazine Article (440) 440
Book Review (356) 356
Book Chapter (299) 299
Trade Publication Article (150) 150
Web Resource (72) 72
Book / eBook (55) 55
Dissertation (41) 41
Conference Proceeding (35) 35
Paper (23) 23
Reference (16) 16
Government Document (14) 14
Data Set (7) 7
Transcript (4) 4
Report (3) 3
Journal / eJournal (2) 2
Library Holding (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26309) 26309
diarrhea (23046) 23046
male (13658) 13658
female (13422) 13422
index medicus (11325) 11325
adult (8147) 8147
middle aged (7390) 7390
infant (6409) 6409
aged (5663) 5663
animals (5564) 5564
diarrhea - etiology (5108) 5108
child, preschool (5048) 5048
diarrhea - drug therapy (4553) 4553
child (4370) 4370
diarrhea - chemically induced (3652) 3652
diarrhea - therapy (3596) 3596
treatment outcome (3477) 3477
children (3402) 3402
patients (3376) 3376
infectious diseases (3365) 3365
health aspects (3273) 3273
gastroenterology & hepatology (3265) 3265
pediatrics (3217) 3217
research (3189) 3189
infections (3178) 3178
care and treatment (3111) 3111
oncology (3083) 3083
antibiotics (2993) 2993
adolescent (2969) 2969
disease (2757) 2757
risk factors (2708) 2708
diarrhea - microbiology (2620) 2620
clinical trials (2514) 2514
medicine, general & internal (2514) 2514
microbiology (2511) 2511
drug therapy (2454) 2454
pharmacology & pharmacy (2323) 2323
anti-bacterial agents - therapeutic use (2320) 2320
infant, newborn (2170) 2170
analysis (2143) 2143
infection (2134) 2134
epidemiology (2085) 2085
cancer (2080) 2080
diagnosis (2072) 2072
mortality (2068) 2068
chemotherapy (2052) 2052
immunology (1916) 1916
therapy (1915) 1915
pain (1902) 1902
aged, 80 and over (1900) 1900
clostridium difficile (1897) 1897
diarrhea - epidemiology (1870) 1870
irritable bowel syndrome (1853) 1853
acute disease (1834) 1834
studies (1812) 1812
fluid therapy (1707) 1707
medical research (1698) 1698
medicine (1696) 1696
prevalence (1647) 1647
inflammatory bowel disease (1643) 1643
probiotics (1635) 1635
bacteria (1628) 1628
feces - microbiology (1624) 1624
research article (1590) 1590
colitis (1586) 1586
constipation (1535) 1535
diarrhea - prevention & control (1511) 1511
retrospective studies (1498) 1498
medicine & public health (1486) 1486
diarrhoea (1476) 1476
prevention (1472) 1472
prospective studies (1471) 1471
double-blind (1442) 1442
drug dosages (1394) 1394
double-blind method (1330) 1330
young adult (1324) 1324
public, environmental & occupational health (1302) 1302
time factors (1301) 1301
diarrhea - diagnosis (1289) 1289
vomiting (1259) 1259
abdomen (1253) 1253
management (1248) 1248
administration, oral (1235) 1235
diarrhea - complications (1233) 1233
chronic disease (1226) 1226
cancer therapies (1224) 1224
diarrhea, infantile - therapy (1215) 1215
hospitals (1214) 1214
pharmaceutical industry (1211) 1211
veterinary sciences (1204) 1204
mice (1178) 1178
diagnosis, differential (1168) 1168
surgery (1164) 1164
gastroenteritis (1151) 1151
metastasis (1144) 1144
abridged index medicus (1142) 1142
gastroenterology (1141) 1141
medicine, experimental (1127) 1127
intestine (1120) 1120
nausea (1117) 1117
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (38) 38
Online Resources - Online (10) 10
Robarts - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Media Commons - Audio Visual (1) 1
Providence Healthcare - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (39180) 39180
German (979) 979
French (845) 845
Spanish (642) 642
Chinese (237) 237
Japanese (225) 225
Italian (192) 192
Russian (162) 162
Polish (147) 147
Dutch (92) 92
Portuguese (83) 83
Swedish (46) 46
Danish (45) 45
Czech (39) 39
Turkish (34) 34
Romanian (33) 33
Hungarian (32) 32
Korean (30) 30
Norwegian (29) 29
Hebrew (26) 26
Finnish (16) 16
Croatian (14) 14
Serbian (9) 9
Slovak (9) 9
Ukrainian (7) 7
Bulgarian (4) 4
Arabic (3) 3
Icelandic (3) 3
Urdu (3) 3
Afrikaans (2) 2
Bosnian (2) 2
Indonesian (2) 2
Persian (2) 2
Latin (1) 1
Lithuanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Serious childhood problems in countries with limited resources
: background book on management of the child with a serious infection or severe malnutrition
by Campbell, Harry and Pierce, N. F. (Nathaniel F.) and World Health Organization. Dept. of Child and Adolescent Health and Development
2004, ISBN 9789241562690, v, 65
Patient Care | Treatment | Malnutrition in children | Child Nutrition Disorders | therapy | Developing Countries | Children | Diagnosis | Infection in children | Communicable Diseases | Child | Diseases
Book
Details down arrow
2. Full Text Bacteriophage therapy
by Sulakvelidze, A and Alavidze, Z and Morris J.G, Jr
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 2001, Volume 45, Issue 3, pp. 649 - 659
RESISTANT | ESCHERICHIA-COLI DIARRHEA | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | PHAGE THERAPY | CALVES | MICE | DETAILED EVALUATION | RESEARCHES | SUPPURATIVE BACTERIAL-INFECTIONS | Anti-Bacterial Agents - therapeutic use | Biological Therapy | Animals | Bacterial Infections - therapy | Bacteriophages - growth & development | Bacterial Infections - drug therapy | Humans | Bacteriophages - physiology | Disease Models, Animal | Minireviews
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Management of toxicities of immune checkpoint inhibitors
by Spain, Lavinia and Diem, Stefan and Larkin, James
Cancer Treatment Reviews, ISSN 0305-7372, 2016, Volume 44, pp. 51 - 60
Highlights • Role of immune checkpoint inhibition in the management of key malignancies. • Description of rates of immune-related adverse events and timing of... 
Hematology, Oncology and Palliative Medicine | Pembrolizumab | Immune-related adverse events | Renal cancer | Ipilimumab | Nivolumab | Lung cancer | Melanoma | Immune-checkpoint inhibitors | OPEN-LABEL | SINGLE-ARM | ANTI-CTLA-4 ANTIBODY | METASTATIC MELANOMA | ONCOLOGY | ADVANCED MELANOMA | LONG-TERM SAFETY | MALIGNANT MESOTHELIOMA | ENTERIC NEUROPATHY | ADVERSE EVENTS | IPILIMUMAB RETREATMENT | Lung Neoplasms - drug therapy | Skin Neoplasms - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - adverse effects | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Adrenal Cortex Hormones - therapeutic use | Diarrhea - chemically induced | Infliximab - therapeutic use | Drug Eruptions - drug therapy | Antineoplastic Agents - adverse effects | Colitis - chemically induced | Antilymphocyte Serum - therapeutic use | Colitis - drug therapy | Carcinoma, Renal Cell - drug therapy | Chemical and Drug Induced Liver Injury - etiology | Pituitary Diseases - chemically induced | Pituitary Diseases - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Drug Eruptions - etiology | Neoplasms - drug therapy | Cyclosporine - therapeutic use | Tacrolimus - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Melanoma - drug therapy | Chemical and Drug Induced Liver Injury - drug therapy | Diarrhea - drug therapy | CTLA-4 Antigen - antagonists & inhibitors | Kidney Neoplasms - drug therapy | Thyroiditis - drug therapy | Thyroiditis - chemically induced | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Phage therapy
by Housby, John N and Mann, Nicholas H
Drug Discovery Today, ISSN 1359-6446, 06/2009, Volume 14, Issue 11-12, pp. 536 - 540
There is a renaissance of interest in the antimicrobial potential of phages as more pathogens become multiply antibiotic resistant. Phage therapy is not a new... 
INFECTIONS | ANTIBIOTICS | PROTECTION | EFFICACY | BACTERIOPHAGE THERAPY | PSEUDOMONAS-AERUGINOSA | BACTEREMIA | ESCHERICHIA-COLI DIARRHEA | PHARMACOLOGY & PHARMACY | MICE | CALVES | Bacterial Infections - virology | Animals | Bacterial Infections - therapy | Bacteriophages - classification | Drug Industry - trends | Genetic Vectors - administration & dosage | Medicine, Chinese Traditional | Drug Industry - methods | Humans | Genetic Vectors - therapeutic use | Bacteriophages - physiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Reduced Acute Bowel Toxicity in Patients Treated With Intensity-Modulated Radiotherapy for Rectal Cancer
by Samuelian, Jason M., D.O and Callister, Matthew D., M.D and Ashman, Jonathan B., M.D., Ph.D and Young-Fadok, Tonia M., M.D and Borad, Mitesh J., M.D and Gunderson, Leonard L., M.D
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 5, pp. 1981 - 1987
Purpose We have previously shown that intensity-modulated radiotherapy (IMRT) can reduce dose to small bowel, bladder, and bone marrow compared with... 
Radiology | Hematology, Oncology and Palliative Medicine | Preoperative radiotherapy | Rectal cancer | Intensity-modulated radiation therapy | CLINICAL TARGET VOLUME | MEGAVOLTAGE COMPUTED-TOMOGRAPHY | WHOLE PELVIC RADIOTHERAPY | RADIATION-THERAPY | ACUTE HEMATOLOGIC TOXICITY | PHASE-II TRIAL | GYNECOLOGIC MALIGNANCIES | ONCOLOGY | CONCURRENT CHEMOTHERAPY | DOSE-VOLUME RELATIONSHIPS | PREOPERATIVE HELICAL TOMOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Humans | Intestines - radiation effects | Middle Aged | Male | Urinary Bladder - radiation effects | Radiotherapy, Intensity-Modulated - adverse effects | Aged, 80 and over | Adult | Female | Retrospective Studies | Rectal Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Radiotherapy Dosage | Chemoradiotherapy - methods | Rectal Neoplasms - surgery | Radiotherapy, Intensity-Modulated - methods | Radiation Injuries - complications | Adenocarcinoma - drug therapy | Rectal Neoplasms - radiotherapy | Enteritis - etiology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Diarrhea - etiology | Radiotherapy, Conformal - adverse effects | Aged | Adenocarcinoma - surgery | Preoperative Period | Radiotherapy, Conformal - methods | Care and treatment | Research | Radiotherapy | Nuclear radiation | Oncology, Experimental | Cancer | Index Medicus | PATIENTS | DIARRHEA | DISEASE INCIDENCE | NEOPLASMS | RECTUM | BONE MARROW | RADIATION DOSES | TOXICITY | CHEMOTHERAPY | ENTERITIS | RADIOLOGY AND NUCLEAR MEDICINE | BLADDER | RADIOTHERAPY | SIDE EFFECTS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Microbiota: a key orchestrator of cancer therapy
by Roy, S and Trinchieri, G
NATURE REVIEWS CANCER, ISSN 1474-175X, 05/2017, Volume 17, Issue 5, pp. 271 - 271
The microbiota is composed of commensal bacteria and other microorganisms that live on the epithelial barriers of the host. The commensal microbiota is... 
IRINOTECAN-INDUCED DIARRHEA | FUSOBACTERIUM-NUCLEATUM | DRUG-PROCESSING GENES | ONCOLOGY | INTESTINAL MICROBIOTA | DNA-DAMAGE RESPONSE | TOLL-LIKE RECEPTORS | GERM-FREE MICE | RANDOMIZED DOUBLE-BLIND | GUT MICROBIOTA | IONIZING-RADIATION | Neoplasms - therapy | Animals | Neoplasms - immunology | Humans | Neoplasms - microbiology | Gastrointestinal Microbiome | Treatment Outcome | Care and treatment | Microbiota (Symbiotic organisms) | Immunotherapy | Research | Health aspects | Methods | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text BACTERIOPHAGE THERAPY
by Summers, William C
Annual Reviews in Microbiology, ISSN 0066-4227, 10/2001, Volume 55, Issue 1, pp. 437 - 451
In 1917, bacteriophages were recognized as epizootic infections of bacteria and were almost immediately deployed for antibacterial therapy and prophylaxis. The... 
infection | dysentery | d'Herelle | prophylaxis | resistance | Infection | Resistance | Dysentery | Prophylaxis | ANTIBIOTICS | ESCHERICHIA-COLI DIARRHEA | MICROBIOLOGY | SUPPURATIVE BACTERIAL-INFECTIONS | PHAGE THERAPY | CALVES | AGENTS | MICE | Bacteriophages | Clinical Trials as Topic | Animals | Bacterial Infections - therapy | Humans | Therapeutic Equivalency | Analysis | Physiological aspects | Immunity | Antibacterial agents | Microbiology | Drug therapy | Bacteria
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
by Burger, Jan A and Tedeschi, Alessandra and Barr, Paul M and Robak, Tadeusz and Owen, Carolyn and Ghia, Paolo and Bairey, Osnat and Hillmen, Peter and Bartlett, Nancy L and Li, Jianyong and Simpson, David and Grosicki, Sebastian and Devereux, Stephen and McCarthy, Helen and Coutre, Steven and Quach, Hang and Gaidano, Gianluca and Maslyak, Zvenyslava and Stevens, Don A and Janssens, Ann and Offner, Fritz and Mayer, Jiří and O’Dwyer, Michael and Hellmann, Andrzej and Schuh, Anna and Siddiqi, Tanya and Polliack, Aaron and Tam, Constantine S and Suri, Deepali and Cheng, Mei and Clow, Fong and Styles, Lori and James, Danelle F and Kipps, Thomas J and RESONATE-2 Investigators
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 25, pp. 2425 - 2437
The Bruton's tyrosine kinase inhibitor ibrutinib was compared with the alkylating agent chlorambucil in patients with chronic lymphocytic leukemia. Ibrutinib... 
MEDICINE, GENERAL & INTERNAL | CLL | CYCLOPHOSPHAMIDE | TYROSINE KINASE | RITUXIMAB | OPEN-LABEL | CHLORAMBUCIL | FLUDARABINE | CANCER | PREVIOUSLY UNTREATED PATIENTS | OBINUTUZUMAB | Pyrazoles - therapeutic use | Chlorambucil - adverse effects | Chlorambucil - therapeutic use | Humans | Male | Antineoplastic Agents - therapeutic use | Fatigue - chemically induced | Diarrhea - chemically induced | Disease-Free Survival | Antineoplastic Agents - adverse effects | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Survival Analysis | Female | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Neutropenia - chemically induced | Pyrazoles - adverse effects | Clinical trials | Treatment outcome | Usage | Lymphocytic leukemia | Drug therapy | Analysis | Chronic lymphatic leukemia | Leukemia | Diarrhea | Fatigue | Nausea | Lymphatic leukemia | Lymphoma | Hemorrhage | Survival | Cough | Chlorambucil | Immunosuppression | Chemotherapy | Vomiting | Immunotherapy | Hemoglobin | Myelosuppression | Neutropenia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Targeted Therapy
by Boucher, JE and Sommers, R
CLINICAL JOURNAL OF ONCOLOGY NURSING, ISSN 1092-1095, 10/2018, Volume 22, Issue 5, pp. 565 - 568
MANAGEMENT | ONCOLOGY | RADIONUCLIDE THERAPY | NURSING | gastroenteropancreatic | carcinoid cancer | GUIDELINES | LU-177-DOTATATE | lutetium Lu 177 dotatate | NEUROENDOCRINE-TUMORS | neuroendocrine tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Intensity-Modulated Radiation Therapy for Anal Malignancies: A Preliminary Toxicity and Disease Outcomes Analysis
by Pepek, Joseph M., M.D and Willett, Christopher G., M.D and Wu, Q. Jackie, Ph.D and Yoo, Sua, Ph.D and Clough, Robert W., B.A and Czito, Brian G., M.D
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 5, pp. 1413 - 1419
Purpose Intensity-modulated radiation therapy (IMRT) has the potential to reduce toxicities associated with chemoradiotherapy in the treatment of anal cancer.... 
Radiology | Hematology, Oncology and Palliative Medicine | Intensity-modulated radiation therapy | Anal cancer | Radiation | Acute toxicity | BONE-MARROW | FLUOROURACIL | WHOLE PELVIC RADIOTHERAPY | WOMEN | ACUTE HEMATOLOGIC TOXICITY | CANCER-PATIENTS | Intensity modulated radiation therapy | CISPLATIN | ONCOLOGY | CONCURRENT CHEMOTHERAPY | PREDICTORS | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Thrombocytopenia - etiology | Humans | Middle Aged | Radiotherapy, Intensity-Modulated - methods | Melanoma - radiotherapy | Male | Treatment Outcome | Carcinoma, Squamous Cell - radiotherapy | Radiotherapy, Intensity-Modulated - adverse effects | Young Adult | Neuroendocrine Tumors - radiotherapy | Rhabdomyosarcoma - radiotherapy | Anus Neoplasms - radiotherapy | Adolescent | Aged, 80 and over | Adult | Diarrhea - etiology | Female | Aged | Leukopenia - etiology | Sarcoma - radiotherapy | Anemia - etiology | Adenocarcinoma - radiotherapy | Index Medicus | GASTROINTESTINAL TRACT | DIARRHEA | NEOPLASMS | DIGESTIVE SYSTEM | IMMUNE SYSTEM DISEASES | INTESTINES | TOXICITY | SYMPTOMS | HEMIC DISEASES | MEDICINE | ORGANS | DISEASES | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | ANEMIAS | SKIN | LEUKOPENIA | BODY | COMBINED THERAPY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
by Loupakis, Fotios and Cremolini, Chiara and Masi, Gianluca and Lonardi, Sara and Zagonel, Vittorina and Salvatore, Lisa and Cortesi, Enrico and Tomasello, Gianluca and Ronzoni, Monica and Spadi, Rosella and Zaniboni, Alberto and Tonini, Giuseppe and Buonadonna, Angela and Amoroso, Domenico and Chiara, Silvana and Carlomagno, Chiara and Boni, Luca and Boni, Corrado and Allegrini, Giacomo and Falcone, Alfredo
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1609 - 1618
In patients with metastatic colon cancer, fluorouracil, oxaliplatin, and irinotecan plus bevacizumab, as compared with fluorouracil and irinotecan plus... 
1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INFUSIONAL FLUOROURACIL | LEUCOVORIN | MANAGEMENT | PHASE-III | GUIDELINES | IRINOTECAN | OXALIPLATIN | CHEMOTHERAPY | FOLFIRI | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male